Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Non-Obese Diabetic Mice
about
Cholinergic Stimulation Prevents the Development of Autoimmune Diabetes: Evidence for the Modulation of Th17 Effector Cells via an IFNγ-Dependent Mechanism.Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.Mechanisms and Therapeutic Relevance of Neuro-immune Communication.Cholinergic Activation Enhances Resistance to Oral Salmonella Infection by Modulating Innate Immune Defense Mechanisms at the Intestinal Barrier.
P2860
Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Non-Obese Diabetic Mice
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Galantamine Attenuates Type 1 ...... ies in Non-Obese Diabetic Mice
@ast
Galantamine Attenuates Type 1 ...... ies in Non-Obese Diabetic Mice
@en
type
label
Galantamine Attenuates Type 1 ...... ies in Non-Obese Diabetic Mice
@ast
Galantamine Attenuates Type 1 ...... ies in Non-Obese Diabetic Mice
@en
prefLabel
Galantamine Attenuates Type 1 ...... ies in Non-Obese Diabetic Mice
@ast
Galantamine Attenuates Type 1 ...... ies in Non-Obese Diabetic Mice
@en
P2093
P2860
P50
P1433
P1476
Galantamine Attenuates Type 1 ...... ies in Non-Obese Diabetic Mice
@en
P2093
Kevin Kwan
Laqueta K Hudson
Peder S Olofsson
Sangeeta S Chavan
P2860
P2888
P356
10.2119/MOLMED.2015.00142
P407
P577
2015-08-17T00:00:00Z
P6179
1068965773